Literature DB >> 7782758

Fatality due to gamma-hydroxybutyric acid (GHB) and heroin intoxication.

S D Ferrara1, L Tedeschi, G Frison, A Rossi.   

Abstract

The first case of fatal intoxication due to ingestion of gamma-hydroxybutyric acid (GHB) and intravenous use of heroin is reported. A 42-year-old man, known to have been a heroin addict and to have taken other psychoactive substances, who had been in treatment with GHB for several months, was found dead. Anatomohistopathologic examination showed generalized visceral congestion, edema and pulmonary anthracosis, chronic bronchitis and chronic active hepatitis. Toxicological findings included fluid and tissue distributions of GHB, morphine and 6-monoacetylmorphine. GHB and morphine concentrations were respectively 11.5 and 0.77 micrograms/mL (blood), 84.3 and 0.3 micrograms/mL (vitreous humor), 258.3 and 1.35 micrograms/mL (urine), 57.0 and 14.3 micrograms/mL (bile), 40.0 and 0.43 micrograms/g (brain), 43.0 and 0.60 micrograms/g (liver), 47.0 and 0.68 micrograms/g (kidney). Blood and urine levels of 6-monoacetylmorphine were 28.5 and 12.1 ng/mL respectively. The presumed mechanism of action and pharmacokinetics of GHB are briefly reviewed, with reference to its therapeutic use and to reports of non-fatal GHB intoxication.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7782758

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  8 in total

1.  Traumatic brain injury after a motor vehicle accident: fact or "fantasy"?

Authors:  D G Caldicott; N Edwards
Journal:  Emerg Med J       Date:  2001-11       Impact factor: 2.740

Review 2.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 3.  Back to the Future - Part 2. Post-mortem assessment and evolutionary role of the bio-medicolegal sciences.

Authors:  Santo Davide Ferrara; Giovanni Cecchetto; Rossana Cecchi; Donata Favretto; Silke Grabherr; Takaki Ishikawa; Toshikazu Kondo; Massimo Montisci; Heidi Pfeiffer; Maurizio Rippa Bonati; Dina Shokry; Marielle Vennemann; Thomas Bajanowski
Journal:  Int J Legal Med       Date:  2017-04-25       Impact factor: 2.686

4.  Behavioral effects of gamma-hydroxybutyrate in humans.

Authors:  Alison Oliveto; William Brooks Gentry; Rhonda Pruzinsky; Kishorchandra Gonsai; Thomas R Kosten; Bridget Martell; James Poling
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

5.  Gamma hydroxybutyrate--a coma inducing recreational drug.

Authors:  J M Ryan; I Stell
Journal:  J Accid Emerg Med       Date:  1997-07

Review 6.  Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse.

Authors:  Lawrence P Carter; Daniel Pardi; Jane Gorsline; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2009-06-02       Impact factor: 4.492

Review 7.  A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder.

Authors:  Fabio Caputo; Teo Vignoli; Claudia Tarli; Marco Domenicali; Giorgio Zoli; Mauro Bernardi; Giovanni Addolorato
Journal:  Int J Environ Res Public Health       Date:  2016-03-05       Impact factor: 3.390

8.  Vitreous humor analysis for the detection of xenobiotics in forensic toxicology: a review.

Authors:  Fabien Bévalot; Nathalie Cartiser; Charline Bottinelli; Laurent Fanton; Jérôme Guitton
Journal:  Forensic Toxicol       Date:  2015-10-28       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.